Skip to main content
. 2021 Aug 5;39(38):5376–5384. doi: 10.1016/j.vaccine.2021.07.093

Table 3.

Regression coefficients and 95% confidence intervals of multiple linear regression models of association between characteristics of acute respiratory illness and IgG concentrations or neutralizing antibody titer in seropositive individuals, adjusted for age, sex or time since onset of symptoms or multiply imputed positive PCR test.

Anti-RBD IgG by LIPS Anti-N IgG by LIPS Anti-N IgG by Abbott Neutralizing antibodies by neutralization assay
Acute respiratory illness 29.0 (−19.0…77.0) 5.0 (−0.1…10.1) 1.5 (−0.1…3.0) 0.6 (−0.7…1.9)
Fever ≥ 38 °C 62.4 (0.6…124.2)a 9.8 (3.4…16.3)b 3.0 (1.1…4.9)b 1.2 (−0.5…2.9)
Chills −10.5 (−73.8…52.8) 1.6 (−5.2…8.4) 0.4 (−1.6…2.5) 0.01 (−1.7…1.7)
Fatigue 14.2 (−37.0…65.5) 4.5 (−0.9…10.0) 1.1 (−0.6…2.7) 0.3 (−1.0…1.7)
Muscle aches 23.3 (−37.0…83.5) 4.2 (−2.3…10.7) 1.3 (−0.6…3.2) 0.5 (−1.1…2.2)
Sore throat −50.1 (118.9…18.7) −2.9 (−10.4…4.6) 0.3 (−2.0…2.5) −0.5 (−2.4…1.3)
Cough 20.9 (−45.3…87.1) 5.6 (−1.5…12.6) 1.7 (−0.4…3.8) 0.6 (−1.2…4.1)
Runny nose 12.3 (−46.4…71.0) 3.8 (−2.5…10.0) 1.5 (−0.3…3.4) 1.0 (−0.5…2.6)
Difficulty breathing 69.7 (−4.1…143.5) 9.3 (1.4…17.1)a 2.3 (−0.1…4.6) 1.0 (−1.0…3.1)
Shortness of breath 53.6 (−25.8…132.9) 9.4 (1.1…17.8)a 2.6 (0.1…5.1)a 1.7 (−0.4…3.9)
Chest pain 46.0 (−31.2…123.3) 8.1 (−0.1…16.4) 3.2 (0.9…5.6)b 1.0 (−1.1…3.1)
Other respiratory symptoms −8.9 (−116.2…98.4) 2.7 (−8.8…14.3) 1.5 (−1.9…5.0) −0.1 (−3.0…2.8)
Headache 4.1 (−49.2…57.4) 1.9 (−3.8…7.6) 0.5 (−1.2…2.2) 0.1 (−1.3…1.6)
Stomach ache −60.2 (−165.4…45.0) −7.6 (−18.9…3.7) −1.0 (−4.4…2.4) −2.0 (−4.8…0.9)
Diarrhea 31.1 (−38.2…100.4) 6.4 (−1.0…13.7) 2.5 (0.4…4.7)a 0.3 (−1.6…2.2)
Hospitalized 102.8 (13.6…192.0)a 10.5 (0.9…20.2)a 2.7 (−0.2…5.6) 1.3 (−1.2…3.8)

Statistically significant regression coefficients are shown in bold.

a

p-value between 0.01 and 0.05, bp-value < 0.01.